PTK2B and cancer: We considered the possibility that stimulating T cells via ectopically expressed muscarinic receptors, whose functions are PTK independent, might contribute to the design of unique therapeutic strategies for cancers by bypassing or enhancing classical TCR signaling pathways and T cell responses to this PTK-independent class of receptors.